Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone Switching for Adherence and Weight in Bipolar Disorder
NCT01293825Phase 4Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jan 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ziprasidone in bipolar disorder (BD), sponsored by University Hospitals Cleveland Medical Center. Started Jan 2011; status: completed.
02
Drugs
ziprasidone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01293825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01293825.